Telomir Pharmaceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $18,793 | $0 |
Gross Profit | 9,396 | -6,006 | ||
EBITDA | -5,068 | -2,188 | -2,898 | -5,990 |
EBIT | -5,069 | -4,375 | -941 | -6,006 |
Net Income | -5,069 | -2,179 | -2,898 | -5,990 |
Net Change In Cash | 0 | 0 | 18,793 | 0 |
Free Cash Flow | -696 | -863 | -605 | -1,002 |
Cash | 754 | 402 | 1,266 | 834 |
Basic Shares | 30,010 | 29,762 | 29,539 | 29,609 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3,942 | |||
EBITDA | -12,194 | -11,428 | -854 | -138 |
EBIT | -24,436 | -3,942 | -1,708 | -276 |
Net Income | -16,532 | -13,071 | -854 | -138 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,070 | -3,859 | -468 | -119 |
Cash | 1,266 | 1 | 1 | 0 |
Basic Shares | 29,539 | 29,609 | 29,609 | 29,609 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.17 |
2025-03-31 | -$0.07 |
2024-12-31 | -$0.10 |
2024-09-30 | -$0.20 |
